Physician-pharmacist collaboration in the management of patients with diabetes resistant to usual care

Diabetes Spectrum

Volumn 21, Issue 3, 2008, Pages 209-214

  Ramser, Kristie L ^a,b   Sprabery, Laura R ^c   George, Christa M ^b   Hamann, Gale L ^a,b,c   Vallejo, Victor A ^c,d   Dorko, Craig S ^c   Kuhl, David A ^a,b  

^a Regional Medical Center Memphis   (United States)

^b UNIVERSITY OF TENNESSEE   (United States)

^c UNIVERSITY OF TENNESSEE GRADUATE SCHOOL OF MEDICINE   (United States)

^d Coastal Inpatient Physicians at Trident Health Systems ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ACETYLSALICYLIC ACID; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN A1C; INSULIN; METFORMIN; SULFONYLUREA DERIVATIVE;

ADULT; AGED; ANAMNESIS; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC DIET; DIABETIC PATIENT; DRUG DOSE TITRATION; FEMALE; GLYCEMIC CONTROL; HEALTH PROGRAM; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INTERVIEW; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL CARE; PATIENT CARE; PATIENT EDUCATION; PATIENT REFERRAL; PHARMACIST; PHYSICIAN; RETROSPECTIVE STUDY; SELF CARE; TREATMENT DURATION; TREATMENT FAILURE;

EID: 52649086851     PISSN: 10409165     EISSN: None     Source Type: Journal    
DOI: 10.2337/diaspect.21.3.209     Document Type: Article

References (18)

1. Centers for Disease Control and Prevention: National diabetes fact sheet: general information and national estimates on diabetes in the United States [article online]. Atlanta, Ga., U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2005. Available online at: http://www.cdc.gov/diabetes/pubs/pdf/ndfs_2005.pdf. Accessed 6 July 2007
2. The DCCT Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
3. U.K. Prospective Diabetes Study Group: Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 321:405-412, 2000
4. American Diabetes Association: Standards of medical care in diabetes - 2007 [Position Statement]. Diabetes Care 30 (Suppl. 1):S4-S41, 2007
5. Resnick HE, Bardsley J, Foster GL, Ratner RE: Achievement of American Diabetes Association Clinical Practice Recommendations among U.S. adults with diabetes, 1999-2002: the National Health and Nutrition Examination Survey. Diabetes Care 29:531-537, 2006
6. Institute of Medicine: Crossing the Quality Chasm: A New Healtb System for the Twenty-first Century. Washington, D.C., National Academy Press, 2001. Available online from http://www.nap.edu/books/ 0309072808/html/. Accessed 6 July 2007
7. Vladeck BC: You can't get there from here: obstacles to improving care of the chronically ill. Health Aff (Millwood) 20:175-179, 2001
8. Wagner EH, Austin BT, Davis C, Hindmarsh M, Schaefer J, Bonomi A: Improving chronic illness care: translating evidence into action. Health Aff (Millwood) 20:64-78, 2001
9. Greco PJ, Eisenberg JM: Changing physicians practices. New Engl J Med 329:1271-1274, 1993
10. Renders CM, Valk GD, Griffin S, Wagner EH, Eijk JT, Assendelft WJ: Interventions to improve the management of diabetes mellitus in primary care, outpatient, and community settings. Cochrane Database Syst Rev Issue 4., Article no. CD001481, 2000
11. Von Korff M, Gruman J, Schaefer J, Curry SJ, Wagner EH: Collaborative management of chronic illness. Ann Intern Med 127:1097-1102, 1997
12. Rothman RL, Malone R, Bryant B, Horlen C, Pignone M: Pharmacist-led, primary care-based disease management improves hemoglobin A1C in high-risk patients with diabetes. Am J Med Qual 18:51-58, 2003
13. Rothman RL, Malone R, Bryant B, Shintani AK, Crigler B, Dewalt DA, Dittus RS, Weinberger M, Pignone MP: A randomized trial of a primary care-based disease management program to improve cardiovascular risk factors and glycated hemoglobin levels in patients with diabetes. Am J Med 11:276-284, 2005
14. Kiel PJ, McCord AD: Pharmacist impact on clinical outcomes in a diabetes disease management program via collaborative practice. Ann Pharmacother 39:1828-1832, 2005
15. McCord AD: Clinical impact of a pharmacist-managed diabetes mellitus drug therapy management service. Pharmacother 26:248-253, 2006
16. Choe HM, Mitrovich S, Dubay D, Haywood RA, Krein SL, Vijan S: Proactive case management of high-risk patients with type 2 diabetes mellitus by a clinical pharmacist: a randomized controlled trial. Am J Manag Care 11:253-260, 2005
17. Coast-Senior EA, Kroner BA, Kelley CL, Trilli LE: Management of patients with type 2 diabetes by pharmacists in primary care clinics. Ann Pharmacother 32:636-641, 1998
18. Grundy SM, Cleeman JI, Metz CNB, Brewer HB Jr, Clark LT, Hunninghake DB, Paternak RC, Smith SC Jr, Stone NJ, National Heart Lung, and Blood Institute; American College of Cardiology Foundation; American Heart Association: Implications of recent clinical trials for the national cholesterol education program adult treatment panel III guidelines: National Cholesterol Education Program Coordinating Committee. Circulation 110:227-239, 2004